Tough Q3 For Roche But Diagnostics Soften The Blow

Biosimilar Competition Keeps Biting

 
• By Kevin Grogan
  
Roche_White_Logo
Rough quarter for the Swiss giant's pharma business • Source: Archive

More from Earnings

More from Business